Director

Steven Barg

Director (Global Co-Head of Engagement, Elliott Investment Management L.P.)·Charles River Laboratories International, Inc.

About

S

t

e

v

e

n

B

a

r

g

i

s

G

l

o

b

a

l

C

o

-

H

e

a

d

o

f

E

n

g

a

g

e

m

e

n

t

a

t

E

l

l

i

o

t

t

I

n

v

e

s

t

m

e

n

t

M

a

n

a

g

e

m

e

n

t

L

.

P

.

P

r

i

o

r

t

o

j

o

i

n

i

n

g

E

l

l

i

o

t

t

i

n

F

e

b

r

u

a

r

y

2

0

2

0

,

M

r

.

B

a

r

g

s

p

e

n

t

3

0

y

e

a

r

s

i

n

i

n

v

e

s

t

m

e

n

t

b

a

n

k

i

n

g

,

m

o

s

t

r

e

c

e

n

t

l

y

a

s

a

P

a

r

t

i

c

i

p

a

t

i

n

g

M

a

n

a

g

i

n

g

D

i

r

e

c

t

o

r

a

t

G

o

l

d

m

a

n

S

a

c

h

s

,

w

h

e

r

e

h

e

e

s

t

a

b

l

i

s

h

e

d

a

n

d

l

e

d

w

h

a

t

b

e

c

a

m

e

t

h

e

f

i

r

m

'

s

G

l

o

b

a

l

A

c

t

i

v

i

s

m

a

n

d

S

h

a

r

e

h

o

l

d

e

r

A

d

v

i

s

o

r

y

p

r

a

c

t

i

c

e

,

f

o

u

n

d

e

d

a

n

d

l

e

d

t

h

e

M

&

A

C

a

p

i

t

a

l

M

a

r

k

e

t

s

p

r

a

c

t

i

c

e

,

a

n

d

r

a

n

A

s

i

a

n

E

q

u

i

t

y

C

a

p

i

t

a

l

M

a

r

k

e

t

s

i

n

H

o

n

g

K

o

n

g

.

A

t

G

o

l

d

m

a

n

S

a

c

h

s

h

e

s

e

r

v

e

d

o

n

b

o

t

h

t

h

e

A

s

i

a

n

a

n

d

G

l

o

b

a

l

E

q

u

i

t

y

C

o

m

m

i

t

m

e

n

t

s

C

o

m

m

i

t

t

e

e

s

a

n

d

w

a

s

G

l

o

b

a

l

H

e

a

d

o

f

D

i

v

e

r

s

i

t

y

f

o

r

t

h

e

I

n

v

e

s

t

m

e

n

t

B

a

n

k

i

n

g

D

i

v

i

s

i

o

n

.

P

r

i

o

r

t

o

G

o

l

d

m

a

n

S

a

c

h

s

,

h

e

s

e

r

v

e

d

a

s

a

M

a

n

a

g

i

n

g

D

i

r

e

c

t

o

r

i

n

E

q

u

i

t

y

C

a

p

i

t

a

l

M

a

r

k

e

t

s

a

t

U

B

S

a

n

d

C

r

e

d

i

t

S

u

i

s

s

e

,

w

i

t

h

p

o

s

t

i

n

g

s

i

n

N

e

w

Y

o

r

k

,

H

o

n

g

K

o

n

g

,

a

n

d

L

o

n

d

o

n

.

M

r

.

B

a

r

g

p

r

e

v

i

o

u

s

l

y

s

e

r

v

e

d

o

n

t

h

e

b

o

a

r

d

s

o

f

C

a

r

d

i

n

a

l

H

e

a

l

t

h

a

n

d

C

a

t

a

l

e

n

t

.

H

e

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

M

a

y

2

0

2

5

,

h

a

v

i

n

g

b

e

e

n

a

p

p

o

i

n

t

e

d

i

n

c

o

n

n

e

c

t

i

o

n

w

i

t

h

t

h

e

C

o

m

p

a

n

y

'

s

C

o

o

p

e

r

a

t

i

o

n

A

g

r

e

e

m

e

n

t

w

i

t

h

t

h

e

E

l

l

i

o

t

t

p

a

r

t

i

e

s

.

H

i

s

q

u

a

l

i

f

i

c

a

t

i

o

n

s

t

o

s

e

r

v

e

a

s

a

d

i

r

e

c

t

o

r

i

n

c

l

u

d

e

h

i

s

s

i

g

n

i

f

i

c

a

n

t

M

&

A

a

n

d

c

a

p

i

t

a

l

m

a

r

k

e

t

s

e

x

p

e

r

t

i

s

e

,

a

s

w

e

l

l

a

s

p

u

b

l

i

c

b

o

a

r

d

e

x

p

e

r

i

e

n

c

e

i

n

t

h

e

C

D

M

O

/

C

R

O

s

p

a

c

e

.

Since May 2025
Age 64
Tenure 1 yr

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) NA Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) AC Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) PG Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) May 2025–present Current role
Elliott Investment Management L.P. Global Co-Head of Engagement Feb 2020 - present
Goldman Sachs Participating Managing Director 30 years in investment banking Established and led the firm's Global Activism and Shareholder Advisory practice; founded and led the M&A Capital Markets practice; ran Asian Equity Capital Markets in Hong Kong; served on the Asian and Global Equity Commitments Committees and was Global Head of Diversity for the Investment Banking Division.
UBS Managing Director, Equity Capital Markets Postings in New York, Hong Kong, and London.
Credit Suisse Managing Director, Equity Capital Markets
Goldman Sachs Participating Managing Director; founder and head of Global Activism and Shareholder Advisory practice until 2019
UBS / Credit Suisse Managing Director, Equity Capital Markets

External roles

Organization Role Dates
Elliott Investment Management L.P. Global Co-Head of Engagement Feb 2020 - present
Cardinal Health Director (former)
Catalent Director (former)

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) Person Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person George Llado, Sr. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Craig B. Thompson Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo